HT-100 increases muscle strength and is safe at low doses in DMD ambulant and non-ambulant boys: Results of HALO-DMD-01 and HALO-DMD02 clinical trials

Escolar D.; Britton A.; Loewy J.; Dykstra K.; Poggio E.; Bush E.; Blaustein M.

首页> 外文期刊>Neuromuscular disorders: NMD >HT-100 increases muscle strength and is safe at low doses in DMD ambulant and non-ambulant boys: Results of HALO-DMD-01 and HALO-DMD02 clinical trials

【24h】

HT-100 increases muscle strength and is safe at low doses in DMD ambulant and non-ambulant boys: Results of HALO-DMD-01 and HALO-DMD02 clinical trials

机译：HT-100可增加肌肉力量，并在低剂量的DMD流动和非流动男孩中安全使用：HALO-DMD-01和HALO-DMD02临床试验的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neuromuscular disorders: NMD》 |2016年第2期|共1页
作者
Escolar D.; Britton A.; Loewy J.; Dykstra K.; Poggio E.; Bush E.; Blaustein M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词

相似文献

外文文献
中文文献
专利

1. HT-100 increases muscle strength and is safe at low doses in DMD ambulant and non-ambulant boys: Results of HALO-DMD-01 and HALO-DMD02 clinical trials [J] . Escolar D., Britton A., Loewy J., Neuromuscular disorders: NMD . 2016,第Suppla2期

机译：HT-100可增加肌肉力量，并在低剂量的DMD流动和非流动男孩中安全使用：HALO-DMD-01和HALO-DMD02临床试验的结果
2. Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial [J] . FlaniganK.M., VoitT., RosalesX.Q., Neuromuscular disorders: NMD . 2014,第1期

机译：单剂量Drisapersen在非迁徙性Duchenne肌营养不良患者中的药代动力学和安全性：一项双盲随机临床试验的结果
3. Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial [J] . FlaniganK.M., VoitT., RosalesX.Q., Neuromuscular disorders: NMD . 2014,第1期

机译：单剂量滴灌的药代动力学和安全性，非驻守肌营养不良患者：双盲随机临床试验结果
4. An Approach to 'Dynamic - DDD (Defined Daily Dose) Monitoring' to Reduce Adverse Clinical Outcomes and Increase Patient Safety: Information Repositories and Event Triggers in Clinical Practice [C] . EsatN. ERYILMAZ Patient safety informatics: adverse drug events, human factors and IT tools for patient medication safety . 2011

机译：一种“动态-DDD（确定的每日剂量）监测”的方法，以减少不良的临床结果并提高患者安全性：临床实践中的信息库和事件触发因素
5. Comparison of effects of a motorized standing program on bone mineral density, lower extremity muscle length and health related quality of life in an ambulatory and non-ambulatory boy with DMD. [D] . Nandakumar, Nidhi. 2011

机译：比较动态站立计划对非卧床和非卧床DMD男孩的骨矿物质密度，下肢肌肉长度和健康相关生活质量的影响。
6. Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial [O] . Kevin M. Flanigan, Thomas Voit, Xiomara Q. Rosales, -1

机译：单剂量Drisapersen在非迁徙性Duchenne肌营养不良患者中的药代动力学和安全性：一项双盲随机临床试验的结果
7. Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial [O] . Flanigan Kevin M., Voit Thomas, Rosales Xiomara Q., 2014

机译：单剂量Drisapersen在非迁徙性Duchenne肌营养不良患者中的药代动力学和安全性：一项双盲随机临床试验的结果

HT-100 increases muscle strength and is safe at low doses in DMD ambulant and non-ambulant boys: Results of HALO-DMD-01 and HALO-DMD02 clinical trials

著录项

相似文献

相关主题

期刊订阅